Senior Manager, Regulatory CMC
Danielle is a senior manager, regulatory CMC at Verve Therapeutics. She has over 12 years of combined CMC expertise in regulatory affairs and analytical development. Prior to joining Verve, Danielle served as a regulatory consultant at Halloran Consulting Group, supporting clients at all stages of drug development as well as from a broad range of modalities and therapeutic areas. Previously, she held analytical development roles at Alnylam Pharmaceuticals and Millennium Pharmaceuticals (now Takeda Oncology). Danielle earned her B.S in Chemistry at Carnegie Mellon University.